Tocilizumab in patients with multisystem Erdheim-Chester disease.

Berti, Alvise; Cavalli, Giulio; Guglielmi, Barbara; Biavasco, Riccardo; Campochiaro, Corrado; Tomelleri, Alessandro; Nicoletti, Roberto; Panzacchi, Andrea; Ferrarini, Marina; Dagna, Lorenzo

Berti, Alvise; Cavalli, Giulio; Guglielmi, Barbara; Biavasco, Riccardo; Campochiaro, Corrado; Tomelleri, Alessandro; Nicoletti, Roberto; Panzacchi, Andrea; Ferrarini, Marina; Dagna, Lorenzo.

Afiliação

Berti A; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Cavalli G; Vita-Salute San Raffaele University, Milan, Italy.
Guglielmi B; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Biavasco R; Vita-Salute San Raffaele University, Milan, Italy.
Campochiaro C; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Tomelleri A; Vita-Salute San Raffaele University, Milan, Italy.
Nicoletti R; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Panzacchi A; Vita-Salute San Raffaele University, Milan, Italy.
Ferrarini M; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Dagna L; Vita-Salute San Raffaele University, Milan, Italy.

Oncoimmunology ; 6(6): e1318237, 2017.

Article em En | MEDLINE | ID: mdl-28680751

Palavras-chave

ErdheimChester disease; inflammation; interleukin-6; non-Langerhans cell histiocytosis; tocilizumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google